Suggested Topics within your search.
Suggested Topics within your search.
- therapy 12
- methods 9
- diagnosis 5
- Drug Therapy 4
- Pharmacology 4
- Treatment 4
- Chemotherapy 3
- Diet therapy 3
- Diseases 3
- Psychotherapy 3
- Anxiety Disorders 2
- Child 2
- Cognitive Therapy 2
- Cognitive therapy 2
- Diagnosis, Differential 2
- Diet Therapy 2
- Genital Diseases, Female 2
- Mental Disorders 2
- Nutrition 2
- Pharmaceutical Preparations 2
- administration & dosage 2
- drug therapy 2
- surgery 2
- therapeutic use 2
- Adolescent 1
- Adolescent psychology 1
- Aged 1
- Aging 1
- Analgesia 1
- Anti-Infective Agents 1
-
5941
Memantine-responsive catatonia secondary to tuberculosis, neurocysticercosis, and pneumococcal pneumonia: A case series
Published 2023-11-01“…Benzodiazepines like lorazepam and electroconvulsive therapy are the conventional treatment modalities for catatonia. …”
Get full text
Article -
5942
Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer
Published 2021-01-01“…Immune check point inhibitor (ICI) therapy can be a potentially effective salvage treatment for anaplastic thyroid cancer (ATC) with progression despite standard of care therapies. …”
Get full text
Article -
5943
Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study
Published 2024-03-01“…The data of 47 patients with AIH who received immunosuppressive therapy from April 2001 to August 2023 were analyzed: 10 men (21 %), 37 women (79 %); the average age was 37 (17–66) years. …”
Get full text
Article -
5944
The Relevance of Interventional Time and Clinical Outcomes in Patients with NSTEMI Based on the GRACE Score
Published 2022-01-01“…Patients were grouped according to the GRACE score and the time from admission to intervention therapy. The Cox multivariate risk regression model was used to analyze the correlation between the GRACE score and the time from admission to intervention therapy with major adverse cardiovascular events (MACEs). …”
Get full text
Article -
5945
-
5946
PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma
Published 2025-02-01“…Prothrombin induced by vitamin K absence II (PIVKA-II) is more sensitive for HCC detection, though its role in systemic therapy remains underexplored. This study aimed to evaluate PIVKA-II in non-AFP-secreting HCC treated with systemic therapy. …”
Get full text
Article -
5947
Prevalence of behavioral risk factors among Ukrainians during war amid existing stress factors
Published 2024-12-01Get full text
Article -
5948
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
Published 2025-01-01“…Our review summarizes accumulated data on the role of cells of the tumor microenvironment and their regulatory molecules in the mechanisms underlying therapeutic effects of immune checkpoint inhibitors, including resistance to therapy. Major question we raise here – which group of patients is the most favorable to achieve durable immunotherapy response in endometrial cancer?…”
Get full text
Article -
5949
Harnessing nanotechnology for cancer treatment
Published 2025-01-01“…Nanotechnology has become a groundbreaking innovation force in cancer therapy, offering innovative solutions to the limitations of conventional treatments such as chemotherapy and radiation. …”
Get full text
Article -
5950
A Network Investigation on Idiopathic Hypogonadotropic Hypogonadism in China
Published 2013-01-01“…The results of our cross-sectional study showed the effectiveness of hormone replacement therapy for IHH and implied that gonadotropin and androgen replacement therapy may be superior to gonadotropin treatment alone.…”
Get full text
Article -
5951
Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α
Published 2025-02-01“…Background: As an uncommon serological pattern, the effect of hepatitis B e antigen/anti-hepatitis B e (HBeAg/anti-HBe) coexistence on peginterferon-α (Peg-IFN-α) therapy in patients with chronic hepatitis B (CHB) remains unknown. …”
Get full text
Article -
5952
Efficacy of Kolofort in Combined Functional Gastroenterological Pathology: an Open Study
Published 2020-12-01“…All patients received Kolofort 2 times a day, 2 tablets per dose for 28 days.Results. The Kolofort therapy improved the clinical symptoms according to the “7x7” questionnaire; the primary mean total score was 17.7 ± 3.6, decreased to 10.3 ± 2.5 past 14 days (p < 0.0001) and to 7.6 ± 1.5 - past 28 days of therapy (p < 0.0001). …”
Get full text
Article -
5953
Disparities in Opioid Use Disorder Treatment Admissions in the United States
Published 2020-06-01“…The fully saturated regression results found that the odds of Cincinnati individuals receiving planned medication-assisted therapy were 0.497 (95% CI, 0.451–0.546; P value < 0.001). …”
Get full text
Article -
5954
Protocol for evaluating the effects of integrating music with taekwondo training in children with autism spectrum disorder: A randomized controlled trial.
Published 2025-01-01“…In the "Taekwondo training with elements of music therapy" group, elements of music therapy will be incorporated into the Taekwondo training. …”
Get full text
Article -
5955
Platelet Rich Plasma in the Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw: Personal Experience and Review of the Literature
Published 2014-01-01“…In our study, we considered 72 patients with BRONJ with nonsurgical therapy, surgical therapy, and surgical therapy with platelet rich plasma (PRP) gel to evaluate its therapeutic effect in promoting ONJ wounds healing. …”
Get full text
Article -
5956
First-line glaucoma monotherapy medication patterns in Finland during 1995-2019 based on a population-based study.
Published 2025-01-01“…Timolol fixed-combinations were the most common second-line glaucoma therapy with a share of 39% after 5 years of follow-up.…”
Get full text
Article -
5957
Mortality Related Risk Factors in High-Risk Pulmonary Embolism in the ICU
Published 2016-01-01“…The treatment of choice for group 1 was thrombolytic therapy in 29 (70.7%) and anticoagulation in 12 (29.3%) patients. …”
Get full text
Article -
5958
Clinical Characteristics and Risk Factors for Multidrug-Resistant Enterobacter cloacae Complex Bacteremia in a Chinese Tertiary Hospital: A Decade Review (2013–2022)
Published 2025-01-01“…MDR ECC accounted for 30.9% (58/188). Previous antibiotic therapy was an independent risk factor for MDR ECC (OR = 3.193, P < 0.020), while appropriate antibiotic therapy significantly reduced the risk (OR = 0.279, P < 0.001). …”
Get full text
Article -
5959
Surgical Treatment Patterns, Healthcare Resource Utilization, and Economic Burden in Patients with Tenosynovial Giant Cell Tumor Who Underwent Joint Surgery in the United States
Published 2022-03-01“…Opioids and nonsteroidal anti-inflammatory drugs (NSAIDs), and physical therapy, occupational therapy, and rehabilitation services, were commonly used during baseline (45%, 40%, and 30%, respectively). …”
Get full text
Article -
5960
Analgesia Evaluation of 2 NSAID Drugs as Adjuvant in Management of Chronic Temporomandibular Disorders
Published 2015-01-01“…Statistical analysis has shown that, after 10 days of treatment, all therapies were effective for pain relief. NSAID therapy promoted analgesia on the third day, while placebo only promoted analgesia in the eighth day. …”
Get full text
Article